MIU LAI NG: Open Payments
NPI 1629612833 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$19,340 in 53 payments from 4 companies in 2025. Trend: 2023 $412 · 2024 $11,506 · 2025 $19,340
Speaker / faculty: $13,100Consulting: $2,570Travel & lodging: $1,953Food & beverage: $1,717
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 20 | $10,754 |
| Gilead Sciences, Inc. | 29 | $8,419 |
| Ipsen Biopharmaceuticals, Inc | 2 | $129 |
| Novo Nordisk Inc | 2 | $38 |
Products named: REZDIFFRA, Livdelzi, IQIRVO, Wegovy.
Industry payments across MA — which companies pay providers there.
